The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection

This article has 0 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

To assess the role of the Omicron BA.1 Spike (S) protein in the pathogenesis of the severe acute respiratory coronavirus 2 (SARS-CoV-2), we generated recombinant viruses harboring the S D614G mutation (rWA1-D614G) and the Omicron BA.1 S gene (rWA1-Omi-S) in the backbone of the ancestral SARS-CoV-2 WA1 strain genome. The recombinant viruses were characterizedin vitroandin vivo. Viral entry, cell-cell fusion, viral plaque size, and viral replication kinetics of the rWA1-Omi-S virus were markedly impaired when compared to the rWA1-D614G virus, demonstrating a lower fusogenicity and ability to spread cell-to-cell of rWA1-Omi-S. To assess the contribution of the Omicron BA.1 S protein to SARS-CoV-2 pathogenesis the pathogenicity of rWA1-D614G and rWA1-Omi-S viruses were compared using a feline model of infection. While the rWA1-D614G-inoculated cats became lethargic and showed increased body temperatures on days 2 and 3 post-infection (pi), rWA1-Omi-S-inoculated cats remained subclinical and gained weight throughout the 14-day experimental period. Animals inoculated with rWA1-D614G presented higher levels of infectious virus shedding in nasal secretions, when compared to rWA1-Omi-S-inoculated animals. In addition, tissue replication of the rWA1-Omi-S was markedly reduced compared to the rWA1-D614G, as evidenced by lowerin situviral RNA and lower viral load in tissues on days 3 and 5 pi. Histologic examination of the nasal turbinate and lungs revealed intense inflammatory infiltration in rWA1-D614G-inoculated animals, whereas rWA1-Omi-S-inoculated cats presented only mild to modest inflammation. Together, these results demonstrate that the S protein is a major virulence determinant for SARS-CoV-2 playing a major role for the attenuated phenotype of the Omicron virus.

Author summary

The SARS-CoV-2 Omicron sublineage BA.1 spread rapidly across the globe in late 2021/early 2022. Experimental studies have shown an overall lower pathogenicity of Omicron BA.1 when compared to the ancestral SARS-CoV-2 lineage B.1 (D614G). Recently, we have demonstrated that the Omicron BA.1.1 variant presents lower pathogenicity when compared to D614G (B.1) lineage in a feline model of SARS-CoV-2 infection. There are over 50 mutations in the Omicron genome, of which more than two thirds are present in the S gene. To assess the role of the Omicron BA.1 S on virus pathogenesis, recombinant viruses harboring the S D614G mutation (rWA1-D614G) and the Omicron BA.1 Spike gene (rWA1-Omi-S) in the backbone of the ancestral SARS-CoV-2 WA1 were characterizedin vitroandin vivo. While the Omicron BA.1 S gene results in early entry into cells, the rWA1-Omi-S presents impaired cell-cell spread and fusogenic activity. Inoculation of cats with the recombinant viruses revealed an attenuated phenotype of rWA1-Omi-S, demonstrating a critical role for S protein on the pathogenicity of SARS-CoV-2 and indicating that the Omi-S is a major determinant of the attenuated disease phenotype of Omicron strains.

Related articles

Related articles are currently not available for this article.